PepGen (PEPG) Interest Expenses (2021 - 2026)
PepGen (PEPG) reported Interest Expenses of $31000.0 for Q1 2026, down 40.38% on a YoY basis from $52000.0 in Q1 2025, and up 10.71% sequentially from $28000.0 in Q2 2025.
PepGen (PEPG) Interest Expenses (2021 - 2026) Analysis & Trends
PepGen (PEPG) has 6 years of Interest Expenses data on file, last reported at $31000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses fell 40.38% year-over-year to $31000.0; the trailing twelve-month figure through Mar 2026 stood at $31000.0 (down 40.38% YoY), and the FY2025 full-year result was $14.6 million, up 386.25% from the prior year.
- Interest Expenses climbed to $31000.0 in Q1 2026, from $28000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $31.0 million in Q1 2023 to a low of $15000.0 in Q3 2024.
- A 5-year average of $6.7 million and a median of $578000.0 in 2024 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses jumped 973.74% in 2023 and tumbled 99.94% in 2024, its largest moves.
- Tracing PEPG's Interest Expenses over 5 years: stood at $12.9 million in 2022, then sank by 94.28% to $737000.0 in 2023, then fell by 21.57% to $578000.0 in 2024, then slumped by 95.16% to $28000.0 in 2025, then climbed by 10.71% to $31000.0 in 2026.
- Business Quant data shows PEPG's Interest Expenses at $31000.0 in Q1 2026, $28000.0 in Q2 2025, and $52000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - | 31,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31,000.00 |
| Mar 31, 2026 | 31,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Dec 31, 2024 | 578,000.00 |
| Dec 31, 2024 | 578,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Jun 30, 2024 | 57,000.00 |
| Jun 30, 2024 | 57,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Dec 31, 2023 | 737,000.00 |
| Dec 31, 2023 | 737,000.00 |
| Sep 30, 2023 | 8.33 Mn |
| Sep 30, 2023 | 8.33 Mn |
| Jun 30, 2023 | 30.15 Mn |
| Jun 30, 2023 | 30.15 Mn |